Shengli Wu

机构：Kunming Institute of Botany, Institute of Organic Chemistry with Centre of Phytochemistry, University of Chinese Academy of Sciences · ORCID：0000-0001-9882-3504

发表论文 53 篇 · 总被引 1157 次 · h-index 20

代表论文

• A Novel Lactate Metabolism-Related Gene Signature for Predicting Clinical Outcome and Tumor Microenvironment in Hepatocellular Carcinoma (2022 · Frontiers in Cell and Developmental Biology · 被引 69)
• Resveratrol improves alcoholic fatty liver disease by downregulating HIF-1α expression and mitochondrial ROS production (2017 · PLoS ONE · 被引 61)
• The incidence and risk factors of portal vein system thrombosis after splenectomy and pericardial devascularization (2015 · The Turkish Journal of Gastroenterology · 被引 40)
• Hypothermic machine perfusion reduces the incidences of early allograft dysfunction and biliary complications and improves 1-year graft survival after human liver transplantation (2019 · Medicine · 被引 30)
• Early prophylactic anticoagulation for portal vein system thrombosis after splenectomy: A systematic review and meta-analysis (2016 · Biomedical Reports · 被引 28)
• The protective effects of estrogen on hepatic ischemia-reperfusion injury in rats by downregulating the Ang II/AT1R pathway (2018 · Biochemical and Biophysical Research Communications · 被引 24)